LifeStance Health Group (NASDAQ:LFST – Get Free Report) and Cencora (NYSE:COR – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation and dividends.
Analyst Ratings
This is a breakdown of recent ratings and target prices for LifeStance Health Group and Cencora, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| LifeStance Health Group | 0 | 4 | 5 | 1 | 2.70 |
| Cencora | 0 | 3 | 13 | 0 | 2.81 |
LifeStance Health Group currently has a consensus target price of $14.86, indicating a potential upside of 7.58%. Cencora has a consensus target price of $381.00, indicating a potential upside of 12.37%. Given Cencora’s stronger consensus rating and higher possible upside, analysts plainly believe Cencora is more favorable than LifeStance Health Group.
Risk & Volatility
Profitability
This table compares LifeStance Health Group and Cencora’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| LifeStance Health Group | 4.29% | 4.82% | 3.30% |
| Cencora | 1.03% | 110.72% | 4.22% |
Institutional & Insider Ownership
85.5% of LifeStance Health Group shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 3.5% of LifeStance Health Group shares are held by company insiders. Comparatively, 0.4% of Cencora shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Valuation and Earnings
This table compares LifeStance Health Group and Cencora”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| LifeStance Health Group | $1.42 billion | 3.69 | $9.66 million | $0.19 | 72.68 |
| Cencora | $337.40 billion | 0.19 | $3.48 billion | $17.92 | 18.92 |
Cencora has higher revenue and earnings than LifeStance Health Group. Cencora is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.
Summary
Cencora beats LifeStance Health Group on 9 of the 15 factors compared between the two stocks.
About LifeStance Health Group
LifeStance Health Group, Inc. is a U.S. provider of outpatient mental health services. The company offers care through in-person clinics and virtual appointments, connecting patients with behavioral health professionals. Its services include psychotherapy, psychiatric evaluations and medication management. LifeStance’s clinicians treat a range of mental health conditions, including anxiety, depression, attention-deficit/hyperactivity disorder and mood disorders. Founded in 2017, LifeStance has expanded its network across the United States.
About Cencora
Cencora, formerly known as AmerisourceBergen, is a global pharmaceutical services company that connects pharmaceutical manufacturers with healthcare providers. Its core business includes sourcing and distributing medicines and other healthcare products to pharmacies, hospitals, health systems and other care providers. The company also provides services supporting specialty pharmaceuticals, including logistics, consulting and solutions for manufacturers and healthcare organizations. These services help manage the handling and delivery of complex medicines and support access to treatments.
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
